A/S Novo Insider Trading $TBRA Tobira Therapeutics, Inc.
Get free email notifications about insider trading for A/S Novo.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of A/S Novo. A/S Novo is 10% Owner in HTG MOLECULAR DIAGNOSTICS, INC ($HTGM) and 10% Owner in BIOMIMETIC THERAPEUTICS, INC. ($BMTI) and 10% Owner in Apollo Endosurgery, Inc. ($LPTN) and 10% Owner in Inogen Inc ($INGN) and 10% Owner in Tobira Therapeutics, Inc. ($TBRA) and 10% Owner in KalVista Pharmaceuticals, Inc. ($KALV) and 10% Owner in CoLucid Pharmaceuticals, Inc. ($CLCD) and 10% Owner in REATA PHARMACEUTICALS INC ($RETA) and 10% Owner in ANAPTYSBIO INC ($ANAB) and 10% Owner in iRhythm Technologies, Inc. ($IRTC) and 10% Owner in Milestone Pharmaceuticals Inc. ($MIST) and 10% Owner in Ophthotech Corp. ($OPHT) and 10% Owner in Flexion Therapeutics Inc ($FLXN) and 10% Owner in Ra Pharmaceuticals, Inc. ($RARX) and 10% Owner in Galera Therapeutics, Inc. ($GRTX) and 10% Owner in Corvus Pharmaceuticals, Inc. ($CRVS) and 10% Owner in Bolt Biotherapeutics, Inc. ($BOLT) and 10% Owner in Checkmate Pharmaceuticals, Inc. ($CMPI) and 10% Owner in Morphic Holding, Inc. ($MORF) and 10% Owner in Praxis Precision Medicines, Inc. ($PRAX) and 10% Owner in Inozyme Pharma, Inc. ($INZY) and 10% Owner in Eargo, Inc. ($EAR) and 10% Owner in Reneo Pharmaceuticals, Inc. ($RPHM) and 10% Owner in Entasis Therapeutics Holdings Inc. ($ETTX) and 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM) and 10% Owner in Nkarta, Inc. ($NKTX) and 10% Owner in Edgewise Therapeutics, Inc. ($EWTX) and 10% Owner in Aligos Therapeutics, Inc. ($ALGS) and 10% Owner in SPRUCE BIOSCIENCES, INC. ($SPRB) and 10% Owner in Harmony Biosciences Holdings, Inc. ($HRMY).
A/S Novo in Tobira Therapeutics, Inc.
Trading Symbol: TBRAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of A/S Novo: 10% Owner
Holdings: 1,914,541 shares
Latest Transaction: Jul 13 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of A/S Novo in Tobira Therapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALGS, ANAB, LPTN, BMTI, BOLT, CMPI, CLCD, CRVS, EAR, EWTX, ETTX, FLXN, GRTX, HRMY, HTGM, INGN, INZY, IRTC, OPHT, KALV, MIST, MIRM, MORF, NKTX, PRAX, RARX, RETA, RPHM, SPRB, TBRA
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 13 2016 | TBRA | Tobira Therapeutic ... | Novo A/S | 10% Owner | Sell | S | 11.88 | 29,884 | 354,944 | 1,875,905 | 1.9 M to 1.9 M (-1.57 %) |
Jul 13 2016 | TBRA | Tobira Therapeutic ... | Novo A/S | 10% Owner | Sell | S | 12.12 | 8,752 | 106,072 | 1,905,789 | 1.9 M to 1.9 M (-0.46 %) |
Jul 13 2016 | TBRA | Tobira Therapeutic ... | Novo A/S | 10% Owner | Sell | S | 12.19 | 20,431 | 249,101 | 1,914,541 | 1.9 M to 1.9 M (-1.06 %) |
Jul 07 2016 | TBRA | Tobira Therapeutic ... | Novo A/S | 10% Owner | Sell | S | 12.03 | 21,869 | 263,150 | 1,934,972 | 2 M to 1.9 M (-1.12 %) |
Jul 07 2016 | TBRA | Tobira Therapeutic ... | Novo A/S | 10% Owner | Sell | S | 12.20 | 59,850 | 730,272 | 1,956,841 | 2 M to 2 M (-2.97 %) |
Jul 07 2016 | TBRA | Tobira Therapeutic ... | Novo A/S | 10% Owner | Sell | S | 12.57 | 10,400 | 130,709 | 2,016,691 | 2 M to 2 M (-0.51 %) |
Jun 30 2016 | TBRA | Tobira Therapeutic ... | Novo A/S | 10% Owner | Sell | S | 12.58 | 27,133 | 341,368 | 2,027,091 | 2.1 M to 2 M (-1.32 %) |
Jun 30 2016 | TBRA | Tobira Therapeutic ... | Novo A/S | 10% Owner | Sell | S | 12.63 | 16,068 | 202,947 | 2,054,224 | 2.1 M to 2.1 M (-0.78 %) |
Jun 30 2016 | TBRA | Tobira Therapeutic ... | Novo A/S | 10% Owner | Sell | S | 14.28 | 2,730 | 38,975 | 2,070,292 | 2.1 M to 2.1 M (-0.13 %) |
Jun 30 2016 | TBRA | Tobira Therapeutic ... | Novo A/S | 10% Owner | Sell | S | 13.77 | 20,883 | 287,651 | 2,073,022 | 2.1 M to 2.1 M (-1.00 %) |
Jun 07 2016 | TBRA | Tobira Therapeutic ... | Novo A/S | 10% Owner | Sell | S | 10.37 | 187,500 | 1,943,906 | 2,093,905 | 2.3 M to 2.1 M (-8.22 %) |
Mar 04 2016 | TBRA | Tobira Therapeutic ... | Novo A/S | 10% Owner | Sell | S | 6.54 | 55,000 | 359,667 | 2,281,405 | 2.3 M to 2.3 M (-2.35 %) |
Mar 04 2016 | TBRA | Tobira Therapeutic ... | Novo A/S | 10% Owner | Sell | S | 6.86 | 25,000 | 171,395 | 2,336,405 | 2.4 M to 2.3 M (-1.06 %) |
Mar 04 2016 | TBRA | Tobira Therapeutic ... | Novo A/S | 10% Owner | Sell | S | 6.92 | 110,000 | 761,024 | 2,361,405 | 2.5 M to 2.4 M (-4.45 %) |
Nov 19 2015 | TBRA | Tobira Therapeutic ... | Novo A/S | 10% Owner | Sell | S | 9.76 | 153,601 | 1,498,685 | 2,471,405 | 2.6 M to 2.5 M (-5.85 %) |
Nov 19 2015 | TBRA | Tobira Therapeutic ... | Novo A/S | 10% Owner | Sell | S | 9.87 | 71,399 | 704,394 | 2,625,006 | 2.7 M to 2.6 M (-2.65 %) |
May 06 2015 | TBRA | Tobira Therapeutic ... | Novo A/S | 10% Owner | Buy | P | 10.62 | 838,041 | 8,899,995 | 2,696,405 | 1.9 M to 2.7 M (+45.10 %) |
Page: 1